Scopolamine Explained

Verifiedfields:changed
Watchedfields:changed
Verifiedrevid:464387972
Width:200
Tradename:Transderm Scop, others
Dailymedid:Scopolamine
Pregnancy Au:B2
Pregnancy Au Comment:[1]
Routes Of Administration:By mouth, transdermal, ophthalmic, subcutaneous, intravenous, sublingual, rectal, buccal, transmucosal, intramuscular
Class:
Atc Prefix:A04
Atc Suffix:AD01
Atc Supplemental:,
Legal Au:S4
Legal Au Comment:/ S2[2]
Legal Uk:POM
Legal Uk Comment:/ P[3] [4]
Legal Us:Rx-only
Legal Us Comment:[5]
Bioavailability:20-40%[6]
Metabolism:Liver (CYP3A4)[7]
Elimination Half-Life:5 hours
Excretion:Kidney
Index2 Label:as salt
Cas Number:51-34-3
Pubchem:3000322
Iuphar Ligand:330
Drugbank:DB00747
Chemspiderid:10194106
Unii:DL48G20X8X
Unii2:451IFR0GXB
Kegg:D00138
Kegg2:D02071
Chebi:16794
Chembl:569713
Pdb Ligand:OW0
Synonyms:Hyoscine
Iupac Name:(–)-(S)-3-Hydroxy-2-phenylpropionic acid (1R,2R,4S,5S,7α,9S)-9-methyl-3-oxa-9-azatricyclo[3.3.1.0<sup>2,4</sup>]non-7-yl ester
C:17
H:21
N:1
O:4
Smiles:OC[C@H](c1ccccc1)C(=O)O[C@@H]2C[C@H]3N(C)[C@@H](C2)[C@@H]4O[C@H]34
Stdinchi:1S/C17H21NO4/c1-18-13-7-11(8-14(18)16-15(13)22-16)21-17(20)12(9-19)10-5-3-2-4-6-10/h2-6,11-16,19H,7-9H2,1H3/t11-,12-,13-,14+,15-,16+/m1/s1
Stdinchikey:STECJAGHUSJQJN-FWXGHANASA-N

Scopolamine, also known as hyoscine,[8] or Devil's Breath,[9] is a natural or synthetically produced tropane alkaloid and anticholinergic drug that is used as a medication to treat motion sickness[10] and postoperative nausea and vomiting.[11] It is also sometimes used before surgery to decrease saliva. When used by injection, effects begin after about 20 minutes and last for up to 8 hours. It may also be used orally and as a transdermal patch since it has been long known to have transdermal bioavailability.[12] [13]

Scopolamine is in the antimuscarinic family of drugs and works by blocking some of the effects of acetylcholine within the nervous system.[12]

Scopolamine was first written about in 1881 and started to be used for anesthesia around 1900.[14] [15] Scopolamine is also the main active component produced by certain plants of the nightshade family, which historically have been used as psychoactive drugs, known as deliriants, due to their antimuscarinic-induced hallucinogenic effects in higher doses.[11] In these contexts, its mind-altering effects have been utilized for recreational and occult purposes.[16] [17] The name "scopolamine" is derived from one type of nightshade known as Scopolia, while the name "hyoscine" is derived from another type known as Hyoscyamus niger, or black henbane.[18] [19] It is on the World Health Organization's List of Essential Medicines.[20]

Medical uses

Scopolamine has a number of formal uses in modern medicine where it is used in its isolated form and in low doses to treat:[21] [22]

It is sometimes used as a premedication, especially to reduce respiratory tract secretions in surgery, most commonly by injection.[21] [22] Common side effects include sleepiness, blurred vision, dilated pupils, and dry mouth.[12] It is not recommended in people with angle-closure glaucoma or bowel obstruction.[12] Whether its use during pregnancy is safe remains unclear, and use during breastfeeding is still cautioned by health professionals and manufacturers of the drug.[28]

Breastfeeding

Scopolamine enters breast milk by secretion. Although no human studies exist to document the safety of scopolamine while nursing, the manufacturer recommends that caution be taken if scopolamine is administered to a breastfeeding woman.[28]

Adverse effects

Adverse effect incidence:[29] [30] [31]

Uncommon (0.1–1% incidence) adverse effects include:

Rare (<0.1% incidence) adverse effects include:

Unknown frequency adverse effects include:

Overdose

Physostigmine, a cholinergic drug that readily crosses the blood–brain barrier, has been used as an antidote to treat the central nervous system depression symptoms of a scopolamine overdose.[32] Other than this supportive treatment, gastric lavage and induced emesis (vomiting) are usually recommended as treatments for oral overdoses.[31] The symptoms of overdose include:[30] [31]

Route of administration

Scopolamine can be taken by mouth, subcutaneously, in the eye, and intravenously, as well as via a transdermal patch.[33]

Pharmacology

Pharmacodynamics

The pharmacological effects of scopolamine are mediated through the drug's competitive antagonism of the peripheral and central muscarinic acetylcholine receptors. Scopolamine acts as a nonspecific muscarinic antagonist at all four (M1, M2, M3, and M4) receptor sites.[34] [35]

In doses higher than intended for medicinal use; the hallucinogenic alteration of consciousness, as well as the deliriousness in particular are tied to the compound's activity at the M1 muscarinic receptor. M1 receptors are located primarily in the central nervous system and are involved in perception, attention and cognitive functioning. Delirium is only associated with the antagonism of postsynaptic M1 receptors and currently other receptor subtypes have not been implicated.[36]

Peripheral muscarinic receptors are part of the autonomic nervous system. M2 receptors are located in the brain and heart, M3 receptors are in salivary glands and M4 receptors are in the brain and lungs.[36] Due to the drug's inhibition of various signal transduction pathways, the decrease in acetylcholine signaling is what leads to many of the cognitive deficits, mental impairments and delirium associated with psychoactive doses. Medicinal effects appear to mostly be tied to activation of the peripheral receptors and only from marginal decreases in acetylcholine signaling.[37]

Although often broadly referred to as simply being 'anticholinergic', antimuscarinic would be more specific and accurate terminology to use for scopolamine, as, for example, it is not known to block nicotinic receptors.[36]

Pharmacokinetics

Scopolamine undergoes first-pass metabolism and about 2.6% is excreted unchanged in urine. It has a bioavailability of 20-40%, reaches peak plasma concentration in about 45 minutes, and in healthy subjects has an average half-life of 5 hours (observed range 2 - 10 hours).[6] Scopolamine is primarily metabolized by the CYP3A4 enzyme, and Grapefruit juice decreases metabolism of scopolamine, consequently increasing plasma concentration.[7]

Biosynthesis in plants

Scopolamine is among the secondary metabolites of plants from Solanaceae (nightshade) family of plants, such as henbane (Hyoscyamus niger), jimson weed (Datura), angel's trumpet (Brugmansia), deadly nightshade (Belladonna), mandrake (Mandragora officinarum), and corkwood (Duboisia).[38] [18]

The biosynthesis of scopolamine begins with the decarboxylation of L-ornithine to putrescine by ornithine decarboxylase. Putrescine is methylated to N-methylputrescine by putrescine N-methyltransferase.[39]

A putrescine oxidase that specifically recognizes methylated putrescine catalyzes the deamination of this compound to 4-methylaminobutanal, which then undergoes a spontaneous ring formation to N-methyl-pyrrolium cation. In the next step, the pyrrolium cation condenses with acetoacetic acid yielding hygrine. No enzymatic activity could be demonstrated to catalyze this reaction. Hygrine further rearranges to tropinone.

Subsequently, tropinone reductase I converts tropinone to tropine, which condenses with phenylalanine-derived phenyllactate to littorine. A cytochrome P450 classified as Cyp80F1[40] oxidizes and rearranges littorine to hyoscyamine aldehyde. In the final step, hyoscyamine undergoes epoxidation catalyzed by 6beta-hydroxyhyoscyamine epoxidase yielding scopolamine.

History

Plants naturally containing scopolamine such as Atropa belladonna (deadly nightshade), Brugmansia (angels trumpet), Datura (Jimson weed), Hyoscyamus niger, Mandragora officinarum, Scopolia carniolica, Latua and Duboisia myoporoides have been known about and used for various purposes in both the New and Old Worlds since ancient times.[41] [42] [43] Being one of the earlier alkaloids isolated from plant sources, scopolamine has been in use in its purified forms, such as various salts, including hydrochloride, hydrobromide, hydroiodide, and sulfate, since its official isolation by the German scientist Albert Ladenburg in 1880,[44] and as various preparations from its plant-based form since antiquity and perhaps prehistoric times.

In 1899, a Dr. Schneiderlin recommended the use of scopolamine and morphine for surgical anaesthesia, and it started to be used sporadically for that purpose.[14] [45] The use of this combination in obstetric anesthesiology (childbirth) was first proposed by Richard von Steinbuchel in 1902 and was picked up and further developed by Carl Gauss in Freiburg, Germany, starting in 1903.[46] The method, which was based on a drug synergy between both scopolamine and morphine came to be known as Dämmerschlaf ("twilight sleep") or the "Freiburg method".[45] [46] It spread rather slowly, and different clinics experimented with different dosages and ingredients. In 1915, the Canadian Medical Association Journal reported, "the method [was] really still in a state of development".[45] It remained widely used in the US until the 1960s, when growing chemophobia and a desire for more natural childbirth led to its abandonment.[47]

Society and culture

Names

Hyoscine hydrobromide is the international nonproprietary name, and scopolamine hydrobromide is the United States Adopted Name. Other names include levo-duboisine, devil's breath, and burundanga.[48] [49]

Australian bush medicine

A bush medicine developed by Aboriginal peoples of the eastern states of Australia from the soft corkwood tree (Duboisia myoporoides) was used by the Allies in World War II to stop soldiers from getting seasick when they sailed across the English Channel on their way to France during the Invasion of Normandy. Later, the same substance was found to be usable in the production of scopolamine and hyoscyamine, which are used in eye surgery, and a multimillion-dollar industry was built in Queensland based on this substance.[50]

Recreational and religious use

While it has been occasionally used recreationally for its hallucinogenic properties, the experiences are often unpleasant, mentally and physically. It is also physically dangerous and officially classified as a deliriant drug, so repeated recreational use is rare.[51] In June 2008, more than 20 people were hospitalized with psychosis in Norway after ingesting counterfeit rohypnol tablets containing scopolamine.[52] In January 2018, 9 individuals were hospitalized in Perth, Western Australia, after reportedly ingesting scopolamine.[53]

The alkaloid scopolamine, when taken recreationally for its psychoactive effect is usually taken in the form of preparations from plants of the genera Datura or Brugmansia, often by adolescents or young adults in order to achieve hallucinations and an altered state of consciousness induced by muscarinic antagonism.[54] [55] In circumstances such as these, the intoxication is usually built on a synergistic, but even more toxic mixture of the additional alkaloids in the plants which includes atropine and hyoscyamine.

Historically, the various plants that produce scopolamine have been used psychoactively for spiritual and magical purposes, particularly by witches in western culture and indigenous groups throughout the Americas such as Native American tribes like the Chumash.[17] [56] [57] [58] When entheogenic preparations of these plants were used, scopolamine was considered to be the main psychoactive compound and was largely responsible for the hallucinogenic effects, particularly when the preparation was made into a topical ointment, most notably flying ointment.[59]

Scopolamine is reported to be the only active alkaloid within these plants that can effectively be absorbed through the skin to cause effects.[13] Different recipes for these ointments were explored in European witchcraft at least as far back as the Early Modern period and included multiple ingredients to help with the transdermal absorption of scopolamine, such as animal fat, as well as other possible ingredients to counteract its noxious and dysphoric effects.[59]

In the Bible, there are multiple mentions of Mandrake, a psychoactive and hallucinogenic plant root that contains scopolamine. It was associated with fertility and (sexual) desire where it was yearned for by Rachel, who apparently was "barren" (infertile) but trying to conceive.[60] [61]

Interrogation

The effects of scopolamine were studied for use as a truth serum in interrogations in the early 20th century,[62] but because of the side effects, investigations were dropped.[63] In 2009, the Czechoslovak state security secret police were proven to have used scopolamine at least three times to obtain confessions from alleged antistate dissidents.[64]

Use in crime

Ingestion of scopolamine can render a victim unconscious for 24 hours or more. In large doses, it can cause respiratory failure and death. The most common seems to be recorded in Colombia, where unofficial estimates put the number of annual scopolamine incidents at approximately 50,000. A travel advisory published by the U.S. Overseas Security Advisory Council (OSAC) in 2012 stated:

Between 1998 and 2004, 13% of emergency-room admissions for "poisoning with criminal intentions" in a clinic of Bogotá have been attributed to scopolamine, and 44% to benzodiazepines.[48] Most commonly, the person has been poisoned by a robber who gave the victim a scopolamine-laced beverage, in the hope that the victim would become unconscious or unable to effectively resist the robbery.[48]

Beside robberies, it is also allegedly involved in express kidnappings and sexual assault.[65] In 2008, the Hospital Clínic in Barcelona introduced a protocol to help medical workers identify cases. In February 2015, Madrid hospitals adopted a similar working document.[65] Hospital Clínic has found little scientific evidence to support this use and relies on the victims' stories to reach any conclusion.[65]

Although poisoning by scopolamine appears quite often in the media as an aid for raping, kidnapping, killing, or robbery, the effects of this drug and the way it is applied by criminals (transdermal injection, on playing cards and papers, etc.) are often exaggerated,[66] [67] [68] especially skin exposure, as the dose that can be absorbed by the skin is too low to have any effect. Scopolamine transdermal patches must be used for hours to days.

There are certain other aspects of the usage of scopolamine in crimes. Powdered scopolamine is referred to as "devil's breath". In popular media and television, it is portrayed as a method to brainwash or control people into being defrauded by their attackers.[69] There is debate whether these claims are true.[70] [71] [72]

Research

Scopolamine is used as a research tool to study memory encoding. Initially, in human trials, relatively low doses of the muscarinic receptor antagonist scopolamine were found to induce temporary cognitive defects.[73] Since then, scopolamine has become a standard drug for experimentally inducing cognitive defects in animals.[74] [75] Results in primates suggest that acetylcholine is involved in the encoding of new information into long-term memory.[76] Scopolamine has been shown to exert a greater impairment on episodic memory, event-related potentials, memory retention and free recall compared to diphenhydramine (an anticholinergic and antihistamine).[77]

Scopolamine produces detrimental effects on short-term memory, memory acquisition, learning, visual recognition memory, visuospatial praxis, visuospatial memory, visuoperceptual function, verbal recall, and psychomotor speed.[78] It does not seem to impair recognition and memory retrieval, though. Acetylcholine projections in hippocampal neurons, which are vital in mediating long-term potentiation, are inhibited by scopolamine.[79] Scopolamine inhibits cholinergic-mediated glutamate release in hippocampal neurons, which assist in depolarization, potentiation of action potential, and synaptic suppression. Scopolamine's effects on acetylcholine and glutamate release in the hippocampus favor retrieval-dominant cognitive functioning. Scopolamine has been used to model the defects in cholinergic function for models of Alzheimer's, dementia, fragile X syndrome, and Down syndrome.[80] [81] [82]

Scopolamine has been identified as a psychoplastogen, which refers to a compound capable of promoting rapid and sustained neuroplasticity in a single dose.[83] It has been, and continues to be investigated as a rapid-onset antidepressant, with a number of small studies finding positive results, particularly in female subjects.[84] [85] [86] [87]

NASA agreed to develop a nasal administration method. With a precise dosage, the NASA spray formulation has been shown to work faster and more reliably than the oral form to treat motion sickness.[88]

Although a fair amount of research has been applied to scopolamine in the field of medicine, its hallucinogenic (psychoactive) effects as well as the psychoactive effects of other antimuscarinic deliriants haven't been extensively researched or as well understood compared to other types of hallucinogens such as psychedelic and dissociative compounds, despite the alkaloid's long history of usage in mind-altering plant preparations.[89]

Notes and References

  1. Web site: Scopolamine Use During Pregnancy . Drugs.com . 6 September 2023 . 21 June 2024 . 21 December 2016 . https://web.archive.org/web/20161221011309/https://www.drugs.com/pregnancy/scopolamine.html . live .
  2. Web site: Poisons Standard October 2020 . Federal Register of Legislation . 30 September 2020 . 23 October 2020 . 25 January 2021 . https://web.archive.org/web/20210125152359/https://www.legislation.gov.au/Details/F2020L01255 . live .
  3. Web site: Hyoscine 400 micrograms/ml Solution for Injection . (emc) . 18 September 2017 . 21 June 2024 . 8 November 2023 . https://web.archive.org/web/20231108023252/https://www.medicines.org.uk/emc/product/3581/smpc . live .
  4. Web site: Kwells 300 microgram tablets Summary of Product Characteristics (SmPC) . (emc) . 2 September 2020 . 21 June 2024 . 2 March 2024 . https://web.archive.org/web/20240302175116/https://www.medicines.org.uk/emc/product/11746/smpc . live .
  5. Web site: Transderm Scop - scopolamine patch, extended release . DailyMed . 14 March 2024 . 21 June 2024 . 30 November 2023 . https://web.archive.org/web/20231130171500/https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b877a694-a1d0-4280-937a-a06820b12a88 . live .
  6. Putcha L, Cintrón NM, Tsui J, Vanderploeg JM, Kramer WG . Pharmacokinetics and oral bioavailability of scopolamine in normal subjects . Pharmaceutical Research . 06 . 6 . 481–485 . June 1989 . 2762223 . 10.1023/A:1015916423156 . 27507555 .
  7. Renner UD, Oertel R, Kirch W . Pharmacokinetics and pharmacodynamics in clinical use of scopolamine . Therapeutic Drug Monitoring . 27 . 5 . 655–665 . October 2005 . 16175141 . 10.1097/01.ftd.0000168293.48226.57 . 32720769 .
  8. Book: Juo PS . Concise Dictionary of Biomedicine and Molecular Biology.. 2001. CRC Press. Hoboken. 978-1-4200-4130-9. 570. 2nd. live. https://web.archive.org/web/20170910183136/https://books.google.com/books?id=Y4DLBQAAQBAJ&pg=PA570. 10 September 2017.
  9. News: Duffy R . Colombian Devil's Breath . . 23 July 2007 . 3 February 2022 . 18 April 2022 . https://web.archive.org/web/20220418081522/https://www.vice.com/en/article/kw3kam/colombian-devil-s-breath-1-of-2 . live .
  10. Web site: 24 October 2022 . About hyoscine hydrobromide . 14 March 2023 . nhs.uk . 14 March 2023 . https://web.archive.org/web/20230314161833/https://www.nhs.uk/medicines/hyoscine-hydrobromide/about-hyoscine-hydrobromide/ . live .
  11. Book: Osbourn AE, Lanzotti V . Plant-derived Natural Products: Synthesis, Function, and Application . 2009 . Springer Science & Business Media . 978-0-387-85498-4 . 5 . live . https://web.archive.org/web/20170910183136/https://books.google.com/books?id=Y8SpVXEng4QC&pg=PA6 . 10 September 2017 .
  12. Web site: Scopolamine. The American Society of Health-System Pharmacists . 8 December 2016. live . https://web.archive.org/web/20161007123115/https://www.drugs.com/monograph/scopolamine.html . 7 October 2016.
  13. Book: Sollmann T . A Manual of Pharmacology and Its Applications to Therapeutics and Toxicology . 8th. W.B. Saunders. Philadelphia and London . 1957.
  14. Book: Keys TE . The history of surgical anesthesia . 1996 . Wood Library, Museum of Anesthesiology . Park Ridge, Ill. . 978-0-9614932-7-1 . 48ff . Reprint . 26 July 2022 . 19 April 2022 . https://web.archive.org/web/20220419151844/https://www.woodlibrarymuseum.org/wp-content/uploads/e-books/w0012pdf.PDF . live .
  15. Book: Fischer J, Ganellin CR . Analogue-based Drug Discovery . 2006. John Wiley & Sons. 978-3-527-60749-5. 551.
  16. Book: Kennedy DO . 2014 . The Deliriants - The Nightshade (Solanaceae) Family . https://books.google.com/books?id=YUNDAgAAQBAJ&pg=PA131 . Plants and the Human Brain . . . 131–137 . 978-0-19-991401-2 . 2013031617 . 17 September 2021 . 17 September 2021 . https://web.archive.org/web/20210917082513/https://books.google.com/books?id=YUNDAgAAQBAJ&pg=PA131 . live .
  17. Book: The encyclopedia of psychoactive plants: ethnopharmacology and its applications. Raetsch C . US: Park Street Press. 2005. 277–282.
  18. Book: The Chambers Dictionary. 1998. Allied Publishers. 978-81-86062-25-8. 788, 1480.
  19. Book: Cattell HW . Lippincott's new medical dictionary: a vocabulary of the terms used in medicine, and the allied sciences, with their pronunciation, etymology, and signification, including much collateral information of a descriptive and encyclopedic character . 25 February 2012 . 1910 . Lippincott . 435 . live . https://web.archive.org/web/20170910183136/https://books.google.com/books?id=W_hEAAAAQAAJ&pg=PA435 . 10 September 2017 .
  20. Book: ((World Health Organization)) . The selection and use of essential medicines 2023: web annex A: World Health Organization model list of essential medicines: 23rd list (2023) . 2023 . 10665/371090 . World Health Organization . World Health Organization . Geneva . WHO/MHP/HPS/EML/2023.02 . free .
  21. Book: 978-0-85711-084-8 . British National Formulary (BNF) . Joint Formulary Committee . 2013 . Pharmaceutical Press . London, UK . 65 . 49, 266, 822, 823 .
  22. Book: Rossi S . 978-0-9805790-9-3 . Australian Medicines Handbook . Adelaide . The Australian Medicines Handbook Unit Trust . 2013 . 2013.
  23. Bitterman N, Eilender E, Melamed Y . Hyperbaric oxygen and scopolamine . Undersea Biomedical Research . 18 . 3 . 167–174 . May 1991 . 1853467 . usurped . 13 August 2008 . https://web.archive.org/web/20080820004729/http://archive.rubicon-foundation.org/2573 . 20 August 2008 .
  24. Williams TH, Wilkinson AR, Davis FM, Frampton CM . Effects of transcutaneous scopolamine and depth on diver performance . Undersea Biomedical Research . 15 . 2 . 89–98 . March 1988 . 3363755 . usurped . https://web.archive.org/web/20080820005139/http://archive.rubicon-foundation.org/2495 . 20 August 2008 .
  25. Williams TH, Wilkinson AR, Davis FM, Frampton CM . Effects of transcutaneous scopolamine and depth on diver performance . Undersea Biomedical Research . 15 . 2 . 89–98 . March 1988 . 3363755 .
  26. Web site: Motion Sickness . Divers Alert Network . 6 November 2022 . 6 November 2022 . https://web.archive.org/web/20221106213435/https://dan.org/health-medicine/health-resources/diseases-conditions/motion-sickness/ . live .
  27. Web site: scopolamine solution - ophthalmic, Isopto . MedicineNet.com . 12 February 2019 . 31 March 2019 . https://web.archive.org/web/20190331204406/https://www.medicinenet.com/scopolamine_drops-ophthalmic/article.htm . live .
  28. Book: Briggs GG, Freeman RK, Yaffe SJ . Scopolamine . Drugs in Pregnancy and Lactation . https://archive.org/details/drugsinpregnancy00gera/page/777 . 1994 . Williams and Wilkins . Baltimore, Maryland . 777–778 . 978-0-683-01060-2 .
  29. Web site: DBL HYOSCINE INJECTION BP. 30 January 2012. TGA eBusiness Services. Hospira Australia Pty Ltd. 22 October 2013. live. https://web.archive.org/web/20170330184646/https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2009-PI-00398-3. 30 March 2017.
  30. Web site: Buscopan Tablets - Summary of Product Characteristics (SPC). electronic Medicines Compendium. Boehringer Ingelheim Limited. 11 September 2013. 22 October 2013. live. https://web.archive.org/web/20131023062458/http://www.medicines.org.uk/emc/medicine/282/SPC/Buscopan+Tablets/. 23 October 2013.
  31. Web site: Kwells 300 microgram tablets - Summary of Product Characteristics . 7 January 2008 . 22 October 2013 . electronic Medicines Compendium . Bayer plc . live . https://web.archive.org/web/20131023061617/http://www.medicines.org.uk/emc/medicine/18845/SPC/Kwells+300+microgram+tablets/ . 23 October 2013 .
  32. Book: Barash PG, Cahalan M, Cullen BF, Stock MC, Stoelting RK . Clinical anesthesia . 2009 . Wolters Kluwer/Lippincott Williams & Wilkins . Philadelphia . 978-0-7817-8763-5 . 346 . 6th .
  33. White PF, Tang J, Song D, Coleman JE, Wender RH, Ogunnaike B, Sloninsky A, Kapu R, Shah M, Webb T . Transdermal scopolamine: an alternative to ondansetron and droperidol for the prevention of postoperative and postdischarge emetic symptoms . Anesthesia and Analgesia . 104 . 1 . 92–96 . January 2007 . 17179250 . 10.1213/01.ane.0000250364.91567.72 . 44784425 . free .
  34. Web site: Google Scholar. scholar.google.com. 16 December 2017. 30 October 2020. https://web.archive.org/web/20201030032647/https://scholar.google.com/scholar?q=scopolamine+nonselective&btnG=&hl=en&as_sdt=0,11. live.
  35. Web site: PDSP Ki Database. 23 July 2020. 23 July 2020. https://web.archive.org/web/20200723204620/https://pdsp.unc.edu/databases/pdsp.php?receptorDD=&receptor=&speciesDD=&species=&sourcesDD=&source=&hotLigandDD=&hotLigand=&testDDRadio=testDDRadio&testLigandDD=2417&testLigand=&referenceDD=&reference=&KiGreater=&KiLess=&kiAllRadio=all&doQuery=Submit+Query. live.
  36. Dawson AH, Buckley NA . Pharmacological management of anticholinergic delirium - theory, evidence and practice . British Journal of Clinical Pharmacology . 81 . 3 . 516–524 . March 2016 . 26589572 . 4767198 . 10.1111/bcp.12839 . Delirium is only associated with the antagonism of post‐synaptic M1 receptors and to date other receptor subtypes have not been implicated .
  37. Lessenger JE, Feinberg SD . Abuse of prescription and over-the-counter medications . Journal of the American Board of Family Medicine . 21 . 1 . 45–54 . 2008 . 18178702 . 10.3122/jabfm.2008.01.070071 . free .
  38. Muranaka T, Ohkawa H, Yamada Y . Continuous Production of Scopolamine by a Culture of Duboisia leichhardtii Hairy Root Clone in a Bioreactor System . Applied Microbiology and Biotechnology . 40 . 2–3 . 219–223 . 1993 . 10.1007/BF00170370 . 45125074 .
  39. Ziegler J, Facchini PJ . Alkaloid biosynthesis: metabolism and trafficking . Annual Review of Plant Biology . 59 . 1 . 735–769 . 2008 . 18251710 . 10.1146/annurev.arplant.59.032607.092730 .
  40. Li R, Reed DW, Liu E, Nowak J, Pelcher LE, Page JE, Covello PS . Functional genomic analysis of alkaloid biosynthesis in Hyoscyamus niger reveals a cytochrome P450 involved in littorine rearrangement . Chemistry & Biology . 13 . 5 . 513–520 . May 2006 . 16720272 . 10.1016/j.chembiol.2006.03.005 . free .
  41. Armando T. Hunziker: The Genera of Solanaceae. A.R.G. Gantner Verlag K.G., Ruggell, Liechtenstein 2001.
  42. Rätsch, Christian, The Encyclopedia of Psychoactive Plants: Ethnopharmacology and Its Applications pub. Park Street Press 2005
  43. Web site: Pharmacognosy and Phytochemistry : Drugs Containing Alkaloids. 16 December 2022. 20 December 2022. https://web.archive.org/web/20221220191611/https://www.pharmacy180.com/article/duboisia-131/#:~:text=Chemical%20Constituents,%2C%20tigloidine%2C%20valtropine%2C%20tiglyoxytropine.. live.
  44. Ladenburg A . Die natürlich vorkommenden mydriatisch wirkenden Alkaloïde . The naturally occurring mydriatic alkaloids . de . Justus Liebigs Annalen der Chemie . January 1881 . 206 . 3 . 274–307 . 10.1002/jlac.18812060303 .
  45. Twilight Sleep: the Dammerschlaf of the Germans . Canadian Medical Association Journal . 5 . 9 . 805–808 . September 1915 . 20310688 . 1584452 .
  46. News: TWILIGHT SLEEP; Is Subject of a New Investigation . The New York Times . 31 January 1915 . 27 June 2024 . 22 April 2023 . https://web.archive.org/web/20230422080953/https://www.nytimes.com/1915/01/31/archives/twilight-sleep-is-subject-of-a-new-investigation.html . live .
  47. News: Finkbeiner A . Labor Dispute. Book review: What a Blessing She Had Chloroform: The Medical and Social Response to the Pain of Childbirth from 1800 to the Present . . 31 October 1999 . 17 June 2018 . 30 October 2020 . https://web.archive.org/web/20201030082813/https://www.nytimes.com/1999/10/31/books/labor-dispute.html . live .
  48. Uribe-Granja MG, Moreno-López CL, Zamora-Suárez A, Acosta PJ . Perfil epidemiológico de la intoxicación con burundanga en la clínica Uribe Cualla S. A. de Bogotá, D. C. . Epidemiological profile of burundanga poisoning at the Uribe Cualla SA clinic in Bogotá, D. C. . es . Acta Neurológica Colombiana . September 2005 . 21 . 3 . 197–201 . PDF . 1 July 2024 . 3 July 2024 . https://web.archive.org/web/20240703045530/https://actaneurologica.com/index.php/anc/article/view/1723/1459 . live .
  49. Mind controller: What is the 'burundanga' drug? . Bell V . 3 March 2011 . April 2011 . Wired UK . live . https://web.archive.org/web/20170811011218/http://www.wired.co.uk/article/mind-controller-1 . 11 August 2017 .
  50. Web site: Visitors to Art of Healing exhibition told how Australian Indigenous bush medicine was given to every allied soldier landing at Normandy on D-Day . King's College London . 7 June 2019 . 2 June 2020 . 2 June 2020 . https://web.archive.org/web/20200602064503/https://www.kcl.ac.uk/news/australian-indigenous-bush-medicine-was-given-to-allied-soldiers-on-d-day . live .
  51. Book: Freye E . Pharmacology and Abuse of Cocaine, Amphetamines, Ecstasy and Related Designer Drugs . Toxicity of Datura Stramonium . Springer . 2010 . Netherlands . 217–218 . 978-90-481-2447-3 . 10.1007/978-90-481-2448-0_34.
  52. News: Bilsykemedisin i falske rohypnol-tabletter . Aftenposten.no . dead . https://web.archive.org/web/20080627021428/http://www.aftenposten.no/nyheter/iriks/article2507100.ece . 27 June 2008 .
  53. News: Perth backpacker overdose linked to common anti-nausea drug. 4 January 2018. ABC News. 4 January 2018. 7 November 2020. https://web.archive.org/web/20201107233116/https://www.abc.net.au/news/2018-01-04/toxicology-results-from-perth-mass-overdose-expected-today/9303330. live.
  54. Fatur K, Kreft S . Common anticholinergic solanaceaous plants of temperate Europe - A review of intoxications from the literature (1966-2018) . Toxicon . 177 . 52–88 . April 2020 . 32217234 . 10.1016/j.toxicon.2020.02.005 . 2020Txcn..177...52F . 213559151 .
  55. Book: Preissel U, Preissel HG . Brugmansia and Datura: Angel's Trumpets and Thorn Apples . Firefly Books . 2002 . Buffalo, NY . 106–129 . 1-55209-598-3 .
  56. Book: Harner M . 1980. The Way of the Shaman. registration. New York . Harper & Row . 978-0-06-250373-2.
  57. Book: Kuklin A . How Do Witches Fly?. DNA Press . February 1999 . 0-9664027-0-7 .
  58. Applegate RB . The Datura Cult Among the Chumash . The Journal of California Anthropology . 1975 . 2 . 1 . 7–17 . 27824805 .
  59. Hansen, Harold A. The Witch's Garden pub. Unity Press 1978
  60. Web site: Genesis 30:14–16 (King James Version). Bible Gateway. 6 January 2014. 7 January 2014. https://web.archive.org/web/20140107035307/http://www.biblegateway.com/passage/?search=Genesis%2030:14-16&version=KJV. live.
  61. Web site: Song of Songs 7:12–13 (King James Version). Bible Gateway. 6 January 2014. 7 January 2014. https://web.archive.org/web/20140107034445/http://www.biblegateway.com/passage/?search=Song%20of%20Songs%207:12-13&version=KJV. live.
  62. House RE . The Use of Scopolamine in Criminology . Texas State Journal of Medicine . 18 . 256–263 . September 1922 .
    Reprinted in: 10.2307/1147361 . House RE . The Use of Scopolamine in Criminology . American Journal of Police Science . 2 . 4 . 328–336 . July–August 1931 . 1147361.
  63. Web site: Bimmerle G . 22 September 1993 . 'Truth' Drugs in Interrogation. CIA.gov . . 14 June 2012 . dead . https://web.archive.org/web/20120927173306/https://www.cia.gov/library/center-for-the-study-of-intelligence/kent-csi/vol5no2/html/v05i2a09p_0001.htm . 27 September 2012 .
  64. News: Gazdík J, Navara L . Svědek: Grebeníček vězně nejen mlátil, ale dával jim i drogy . A witness: Grebeníček not only beat prisoners, he also administered drugs to them . cs . . 8 August 2009 . 10 August 2009 . live . https://web.archive.org/web/20090811062349/http://zpravy.idnes.cz/svedek-grebenicek-vezne-nejen-mlatil-ale-daval-jim-i-drogy-pmd-/domaci.asp?c=A090807_205833_domaci_vel . 11 August 2009 .
  65. News: Domínguez I . Burundanga: the stealth drug that cancels the victim's willpower . 25 July 2016 . 12 August 2016 . Crime . El País, Madrid . live . https://web.archive.org/web/20160820222322/http://elpais.com/elpais/2016/07/25/inenglish/1469445136_776085.html?id_externo_promo=ob-externo-english . 20 August 2016 .
  66. Web site: Burundanga Business Card Drug Warning . Hoax-Slayer.com . 12 October 2008. live. https://web.archive.org/web/20090307163535/http://www.hoax-slayer.com/burundanga-warning.shtml. 7 March 2009.
  67. News: Beware the Burundanga Man! . About.com Entertainment. 19 December 2016. live. https://web.archive.org/web/20170110140952/http://urbanlegends.about.com/od/crime/a/burundanga.htm. 10 January 2017.
  68. News: Burundanga/Scopolamine Warning. Mikkelson D . snopes.com . 19 December 2016.
  69. Reichert S, Lin C, Ong W, Him CC, Hameed S . Million dollar ride: Crime committed during involuntary scopolamine intoxication . Canadian Family Physician . 63 . 5 . 369–370 . May 2017 . 28500194 . 5429053 . live . 22 April 2021 . https://web.archive.org/web/20210422180516/https://www.cfp.ca/content/cfp/63/5/369.full.pdf .
  70. Web site: Anderson L . Devil's Breath: Urban Legend or the World's Most Scary Drug? . Drugs.com . 9 July 2019 . 23 June 2019 . https://web.archive.org/web/20190623203809/https://www.drugs.com/illicit/devils-breath.html . live .
  71. News: 2 September 2015 . 'Devil's breath' aka scopolamine: can it really zombify you? . The Guardian . 4 January 2019 . Saner E . 4 January 2019 . https://web.archive.org/web/20190104180116/https://www.theguardian.com/society/shortcuts/2015/sep/02/devils-breath-aka-scopolamine-can-it-really-zombify-you . live .
  72. Web site: Mikkelson . Barbara . 2008-05-11 . FACT CHECK: Burundanga/Scopolamine Warning . 2024-08-01 . Snopes . en.
  73. Drachman DA, Leavitt J . Human memory and the cholinergic system. A relationship to aging? . Archives of Neurology . 30 . 2 . 113–121 . February 1974 . 4359364 . 10.1001/archneur.1974.00490320001001 .
  74. Hasselmo ME, Wyble BP . Free recall and recognition in a network model of the hippocampus: simulating effects of scopolamine on human memory function . Behavioural Brain Research . 89 . 1–2 . 1–34 . December 1997 . 9475612 . 10.1016/s0166-4328(97)00048-x . 584350 .
  75. More SV, Kumar H, Cho DY, Yun YS, Choi DK . Toxin-Induced Experimental Models of Learning and Memory Impairment . International Journal of Molecular Sciences . 17 . 9 . 1447 . September 2016 . 27598124 . 5037726 . 10.3390/ijms17091447 . free .
  76. Ridley RM, Bowes PM, Baker HF, Crow TJ . An involvement of acetylcholine in object discrimination learning and memory in the marmoset . Neuropsychologia . 22 . 3 . 253–263 . 1984 . 6431311 . 10.1016/0028-3932(84)90073-3 . 7110504 .
  77. Curran HV, Pooviboonsuk P, Dalton JA, Lader MH . Differentiating the effects of centrally acting drugs on arousal and memory: an event-related potential study of scopolamine, lorazepam and diphenhydramine . Psychopharmacology . 135 . 1 . 27–36 . January 1998 . 9489931 . 10.1007/s002130050482 . 9872819 .
  78. Flicker C, Serby M, Ferris SH . Scopolamine effects on memory, language, visuospatial praxis and psychomotor speed . Psychopharmacology . 100 . 2 . 243–250 . February 1990 . 2305013 . 10.1007/bf02244414 . 24645744 .
  79. Lisboa SF, Vila-Verde C, Rosa J, Uliana DL, Stern CA, Bertoglio LJ, Resstel LB, Guimaraes FS . Tempering aversive/traumatic memories with cannabinoids: a review of evidence from animal and human studies . Psychopharmacology . 236 . 1 . 201–226 . January 2019 . 30604182 . 10.1007/s00213-018-5127-x . 58655082 .
  80. Qin M, Zeidler Z, Moulton K, Krych L, Xia Z, Smith CB . Endocannabinoid-mediated improvement on a test of aversive memory in a mouse model of fragile X syndrome . Behavioural Brain Research . 291 . 164–171 . September 2015 . 25979787 . 5003021 . 10.1016/j.bbr.2015.05.003 .
  81. Book: Lott IT . Down Syndrome: From Understanding the Neurobiology to Therapy . Neurological phenotypes for Down syndrome across the life span . Progress in Brain Research . 197 . 101–21 . 2012 . 22541290 . 10.1016/b978-0-444-54299-1.00006-6 . 3417824. 978-0-444-54299-1 .
  82. Lagalwar S, Bordayo EZ, Hoffmann KL, Fawcett JR, Frey WH . Anandamides inhibit binding to the muscarinic acetylcholine receptor . Journal of Molecular Neuroscience . 13 . 1–2 . 55–61 . 1999 . 10691292 . 10.1385/jmn:13:1-2:55 . 22731716 .
  83. Olson DE . Psychoplastogens: A Promising Class of Plasticity-Promoting Neurotherapeutics . Journal of Experimental Neuroscience . 12 . 1179069518800508 . 19 September 2018 . 30262987 . 10.1177/1179069518800508 . 6149016 . 52877093 .
  84. Drevets WC, Zarate CA, Furey ML . Antidepressant effects of the muscarinic cholinergic receptor antagonist scopolamine: a review . Biological Psychiatry . 73 . 12 . 1156–1163 . June 2013 . 23200525 . 4131859 . 10.1016/j.biopsych.2012.09.031 .
  85. Hasselmann H . Scopolamine and depression: a role for muscarinic antagonism? . CNS & Neurological Disorders Drug Targets . 13 . 4 . 673–683 . 2014 . 24938776 . 10.2174/1871527313666140618105710 .
  86. Jaffe RJ, Novakovic V, Peselow ED . Scopolamine as an antidepressant: a systematic review . Clinical Neuropharmacology . 36 . 1 . 24–26 . 2013 . 23334071 . 10.1097/wnf.0b013e318278b703 . 19740245 .
  87. Wohleb ES, Wu M, Gerhard DM, Taylor SR, Picciotto MR, Alreja M, Duman RS . GABA interneurons mediate the rapid antidepressant-like effects of scopolamine . The Journal of Clinical Investigation . 126 . 7 . 2482–2494 . July 2016 . 27270172 . 4922686 . 10.1172/JCI85033 .
  88. NASA Signs Agreement to Develop Nasal Spray for Motion Sickness . NASA . 26 July 2023 . 21 June 2024 . 15 June 2024 . https://web.archive.org/web/20240615023409/https://www.nasa.gov/news-release/nasa-signs-agreement-to-develop-nasal-spray-for-motion-sickness/ . live .
  89. Volgin AD, Yakovlev OA, Demin KA, Alekseeva PA, Kyzar EJ, Collins C, Nichols DE, Kalueff AV . Understanding Central Nervous System Effects of Deliriant Hallucinogenic Drugs through Experimental Animal Models . ACS Chemical Neuroscience . 10 . 1 . 143–154 . January 2019 . 30252437 . 10.1021/acschemneuro.8b00433 . 52824516 .

This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Scopolamine".

Except where otherwise indicated, Everything.Explained.Today is © Copyright 2009-2024, A B Cryer, All Rights Reserved. Cookie policy.